Inventiva (IVA) IPO Opens Modestly Higher
Get Alerts IVA Hot Sheet
Join SI Premium – FREE
Today's IPO for Inventiva (NASDAQ: IVA) opened for trading at $15.13 after pricing at $14.40.
Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC are acting as Joint Global Coordinators and bookrunners for the Offering. H.C. Wainwright & Co., LLC is acting as lead manager and Roth Capital Partners, LLC and KBC Securities USA LLC are acting as co-managers for the Offering.
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need.
Create E-mail Alert Related Categories
IPOsRelated Entities
Stifel, Jefferies & Co, Roth Capital, IPO, H.C. Wainwright, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share